ANI Pharma
ANIP----
ANI Pharma (ANIP)
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
ANI Pharma Analyst Rating
View MoreForecast & Rating
Jul 23, 2026Price forecast
$110.0041.66%
Forecast & RatingBuy
8analysts
- Strong buy50.00%
- Buy37.50%
- Hold12.50%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · 1 day ago, 01:14 AM
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Consensus Rating of "Moderate Buy" from Analysts
- benzinga_article · 1 day ago, 05:25 AM
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?
- Market Beat · 1 day ago, 03:52 AM
Sanctuary Advisors LLC Takes Position in ANI Pharmaceuticals, Inc. $ANIP
- StockTitan · 2 days ago, 09:50 PM
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET | ANIP Stock News
- PUBT · Jul 14 at 03:02 PM
ANI Pharmaceuticals SVP, General Counsel Meredith Cook disposes of 500 common shares for $40,920
- GlobeNewswire · Jul 13 at 05:50 AM
ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chronic Non-Infectious Uveitis
